39652-32-9

Basic information

• Product Name: 3-CHLORO-4-METHYLBENZYL ALCOHOL
• Synonyms: (3-Chloro-4-methylphenyl)methanol;Benzenemethanol, 3-chloro-4-methyl-;3-CHLORO-4-METHYLBENZYL ALCOHOL;TIMTEC-BB SBB008274;3-chloro-4-methylbenzyl alcohol, tech., mixture of isomers;3-CHLORO-4-METHYLBENZYL ALCOHOL, TECHNICAL GRADE;3-Chloro-4-methylbenzenemethanol;3-Chloro-4-methylbenzyl
• CAS NO: 39652-32-9
• Molecular Formula: C₈H₉ClO
• Molecular Weight: 156.61
• EINECS: 254-566-0
• Product Categories: Benzhydrols, Benzyl & Special Alcohols
• Mol File: 39652-32-9.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 137-138°C 7mm
• Flash Point: 106.3 °C
• Appearance: /Liquid
• Density: 1.191 g/cm³
• Vapor Pressure: 0.0103mmHg at 25°C
• Refractive Index: 1.558
• CAS DataBase Reference: 3-CHLORO-4-METHYLBENZYL ALCOHOL(CAS DataBase Reference)
• NIST Chemistry Reference: 3-CHLORO-4-METHYLBENZYL ALCOHOL(39652-32-9)
• EPA Substance Registry System: 3-CHLORO-4-METHYLBENZYL ALCOHOL(39652-32-9)

Safety Data

• Hazard Codes: Xi
• Statements: 36
• Hazardous Substances Data: 39652-32-9(Hazardous Substances Data)

Usage

Uses

It is used in the synthesis of heterocycles on the basis of arylation products of unsaturated compounds.

InChI:InChI=1/C8H9ClO/c1-6-2-3-7(5-10)4-8(6)9/h2-4,10H,5H2,1H3

Upstream product

• 3411-03-8 3-Chlor-4-methyl-benzaldehyd 
• 219764-60-0 {2-chloro-4-[(phenylmethyl)oxy]phenyl}methanol 
• 5162-82-3 3-chloro-4-methylbenzoic acid 

Downstream Products

• 2719-40-6 1-methyl-2-chloro-4-chloromethylbenzene 
• 21423-81-4 3-chloro-4-methylbenzonitrile 
• 24377-95-5 3-chloro-4-methylbenzamide 
• 107947-94-4 1,3-bis(3-chloro-4-methylphenyl)urea 
• 3411-03-8 3-Chlor-4-methyl-benzaldehyd 

Relevant articles and documents

INHIBITORS OF ALPHA 2 BETA 1 INTEGRIN AND METHODS OF USE THEREOF

Disclosed herein, inter alia, are inhibitors of alpha 2 beta 1 integrin and methods of using the same.

HISTONE DEMETHYLASE INHIBITORS

Provided herein are substituted pyrazolylpyridine, pyrazolylpyridazine, and pyrazolylpyrimidine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.

IMIDAZOLE COMPOUNDS AND MEDICINAL USE THEREOF

Imidazole compounds represented by general formula (I): wherein each symbol is as defined in the specification, and salts thereof, and a pharmaceutical composition containing same are provided. These compounds are useful in treating the diseases curable based on a hypoglycemic action, and the diseases curable based on a cGMP-PDE inhibitory action, a smooth muscle relaxing action, a bronchodilating action, a vasodilating action, a smooth muscle cell inhibitory action and an allergy inhibitory action.